Rofo 2021; 193(03): 289-297
DOI: 10.1055/a-1231-5649
Interventional Radiology

Effectiveness of Superior Hypogastric Plexus Block for Pain Control Compared to Epidural Anesthesia in Women Requiring Uterine Artery Embolization for the Treatment of Uterine Fibroids – A Retrospective Evaluation

Effektivität und Sicherheit der Blockade des Plexus hypogastricus superior zur Schmerzkontrolle im Vergleich zur Epiduralanästhesie bei arterieller Embolisation in der Myombehandlung – eine restrospektive Evaluation
Amer Malouhi
1   Institut für Diagnostische und Interventionelle für Radiologie, Universitätsklinikum Jena IDIR, Jena, Germany
,
Rene Aschenbach
1   Institut für Diagnostische und Interventionelle für Radiologie, Universitätsklinikum Jena IDIR, Jena, Germany
,
Anna Erbe
1   Institut für Diagnostische und Interventionelle für Radiologie, Universitätsklinikum Jena IDIR, Jena, Germany
,
Zbigniew Owsianowski
2   Gynäkologie & onkologische Gynäkologie, Klinik Hallerwiese, Nurnberg, Germany
,
Stefan Rußwurm
3   Abteilung für Anästhesie, Hufeland Klinikum GmbH, Bad Langensalza, Germany
,
Ingo B. Runnebaum
4   Klinik für Frauenheilkunde und Fortpflanzungsmedizin, Universitätsklinikum, Jean, Germany
,
Ulf Teichgräber
1   Institut für Diagnostische und Interventionelle für Radiologie, Universitätsklinikum Jena IDIR, Jena, Germany
› Author Affiliations

Abstract

Purpose To assess the effectiveness of pain management with superior hypogastric plexus block (SHPB) compared to epidural anesthesia (EDA) in women requiring uterine artery embolization (UAE).

Materials and Methods In this retrospective, single-center, non-randomized trial we included 79 women with symptomatic uterine fibroids who were scheduled for percutaneous, transcatheter UAE. According to their informed decision, the women were assigned to two different approaches of pain management including either SHPB or EDA. The effectiveness outcome measure was patient reported pain using a numeric rating scale ranging from 1 to 10. The pain score was assessed at UAE, 2 hours thereafter, and at subsequent intervals of 6 hours up to 36 hours after intervention.

Results Treatment groups did not differ significantly regarding age, pain score for regular menstrual cramps, uterine fibroid size, location, and symptoms of uterine fibroids. During UAE and up to 6 hours thereafter, women who received SHPB experienced stronger pain than those who received EDA (mean pain score during UAE: 3.3 vs. 1.5, p < 0.001; at 2 hours: 4.4 vs. 2.8, p = 0.012; at 6 hours: 4.4 vs. 2.6, p = 0.021). The maximum pain level was 5.8 ± 2.9 with SHPB and 4.5 ± 2.9 with EDA (p = 0.086). Women with a history of severe menorrhagia tended to experience worse pain than those without (regression coefficient 2.5 [95 % confidence interval –0.3 to 5.3], p = 0.076).

Conclusion Among women who underwent UAE, pain management including SHPB resulted in stronger pain during and after the procedure than pain treatment including EDA.

Key Points:

  • Pain control with superior hypogastric plexus block was worse than epidural anesthesia.

  • Peak of pain was at 12 hours after uterine artery embolization.

  • Maximum pain was independent from uterine fibroid size or location.

Citation Format

  • Malouhi A, Aschenbach R, Erbe A et al. Effectiveness of Superior Hypogastric Plexus Block for Pain Control Compared to Epidural Anesthesia in Women Requiring Uterine Artery Embolization for the Treatment of Uterine Fibroids – A Retrospective Evaluation. Fortschr Röntgenstr 2021; 193: 289 – 297

Zusammenfassung

Ziel Bestimmung der Wirksamkeit der Schmerzbehandlung durch Blockade des Plexus hypogastricus superior (superior hypogastric plexus block; SHPB) verglichen mit einer Epiduralanästhesie (EDA) bei Embolisation der Uterusarterien (uterine artery embolization; UAE).

Material und Methoden In diese retrospektive, monozentrische, nicht randomisierte Studie wurden 79 Frauen mit symptomatischem Uterusmyom eingeschlossen, für die eine perkutane UAE geplant war. Die Schmerzkontrolle erfolgte entweder mit Unterstützung des SHPB oder der EDA. Ergebnisparameter zur Wirksamkeit war die Schmerzstärke auf einer Skala von 1 bis 10. Abgefragt wurde die Schmerzstärke während sowie 2 Stunden nach UAE und jeweils im Abstand von 6 Stunden bis 36 Stunden nach der UAE.

Ergebnisse Die Behandlungsgruppen unterschieden sich nicht signifikant in Hinblick auf Alter, Schmerzstärke bei vorangegangenen Menstruationen, Größe und Lage der Myome sowie Symptome. Frauen, bei denen ein SHPB vorgenommen wurde, hatten stärkere Schmerzen als diejenigen, die eine EDA erhielten (mittlere Schmerzstärke während der UAE: 3,3 vs. 1,5, p < 0,001; nach 2 Stunden: 4,4 vs. 2,8, p = 0,012; nach 6 Stunden: 4,4 vs. 2,6, p = 0,021). Die maximale Schmerzstärke betrug 5,8 ± 2,9 mit SHPB und 4,5 ± 2,9 mit EDA (p = 0,086). Patientinnen, mit Menorrhagien in der Vorgeschichte neigten zu stärkeren Schmerzen als andere (Regressionskoeffizient 2,5 [95 %-Konfidenzintervall –0,3 bis 5,3], p = 0,076).

Schlussfolgerung Frauen, bei denen eine Embolisation der Uterusarterien durchgeführt wurde, empfanden während und nach dem Eingriff unter einem SHPB stärkere Schmerzen als mit EDA.

Kernaussagen:

  • Die Schmerzkontrolle durch Blockade des Plexus hypogastricus superior war der Epiduralanästhesie unterlegen.

  • Die Schmerzen erreichten 12 Stunden nach Embolisation ihren Höhepunkt.

  • Die maximale Schmerzstärke war unabhängig von der Größe und Lage des Myoms.



Publication History

Received: 11 May 2020

Accepted: 20 July 2020

Article published online:
03 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Edwards RD, Moss JG, Lumsden MA. et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007; 356: 360-370
  • 2 de Bruijn AM, Ankum WM, Reekers JA. et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 2016; 215: 745 e741-745 e712
  • 3 Ruuskanen A, Sipola P, Hippelainen M. et al. Pain after uterine fibroid embolisation is associated with the severity of myometrial ischaemia on magnetic resonance imaging. European radiology 2009; 19: 2977-2985
  • 4 Mishra S, Bhatnagar S, Rana SP. et al. Efficacy of the anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain in advanced gynecological cancer patients. Pain medicine (Malden, Mass) 2013; 14: 837-842
  • 5 Rapp H, Ledin Eriksson S, Smith P. Superior hypogastric plexus block as a new method of pain relief after abdominal hysterectomy: double-blind, randomised clinical trial of efficacy. BJOG: an international journal of obstetrics and gynaecology 2017; 124: 270-276
  • 6 Yoon J, Valenti D, Muchantef K. et al. Superior Hypogastric Nerve Block as Post-Uterine Artery Embolization Analgesia: A Randomized and Double-Blind Clinical Trial. Radiology 2018; 289: 248-254
  • 7 Binkert CA, Hirzel FC, Gutzeit A. et al. Superior Hypogastric Nerve Block to Reduce Pain After Uterine Artery Embolization: Advanced Technique and Comparison to Epidural Anesthesia. Cardiovascular and interventional radiology 2015; 38: 1157-1161
  • 8 Bosscher H. Blockade of the superior hypogastric plexus block for visceral pelvic pain. Pain practice: the official journal of World Institute of Pain 2001; 1: 162-170
  • 9 Gunduz OH, Kenis-Coskun O. Ganglion blocks as a treatment of pain: current perspectives. Journal of pain research 2017; 10: 2815-2826
  • 10 Rasuli P, Jolly EE, Hammond I. et al. Superior hypogastric nerve block for pain control in outpatient uterine artery embolization. Journal of vascular and interventional radiology: JVIR 2004; 15: 1423-1429
  • 11 Spencer EB, Stratil P, Mizones H. Clinical and periprocedural pain management for uterine artery embolization. Seminars in interventional radiology 2013; 30: 354-363
  • 12 Kuthiala G, Chaudhary G. Ropivacaine: A review of its pharmacology and clinical use. Indian journal of anaesthesia 2011; 55: 104-110
  • 13 Rasuli P, Sabri A, Hammond I. et al. Outpatient uterine artery embolization for symptomatic fibroids: short- and long-term single institution-based outcomes. Journal of obstetrics and gynaecology Canada: JOGC = Journal d’obstetrique et gynecologie du Canada: JOGC 2013; 35: 156-163
  • 14 Konstantatos AH, Kavnoudias H, Stegeman JR. et al. A randomized, double-blind, placebo-controlled study of preemptive oral oxycodone with morphine patient-controlled anesthesia for postoperative pain management in patients undergoing uterine artery embolization for symptomatic uterine fibroids. Cardiovascular and interventional radiology 2014; 37: 1191-1197
  • 15 Freire GM, Cavalcante RN, Motta-Leal-Filho JM. et al. Controlled-release oxycodone improves pain management after uterine artery embolisation for symptomatic fibroids. Clinical radiology 2017; 72: 428 e421-428 e425
  • 16 Kaufman Y, Hirsch I, Ostrovsky L. et al. Pain relief by continuous intraperitoneal nebulization of ropivacaine during gynecologic laparoscopic surgery – a randomized study and review of the literature. Journal of minimally invasive gynecology 2008; 15: 554-558
  • 17 Pirro N, Ciampi D, Champsaur P. et al. The anatomical relationship of the iliocava junction to the lumbosacral spine and the aortic bifurcation. Surgical and radiologic anatomy: SRA 2005; 27: 137-141
  • 18 Gofeld M, Lee CW. Ultrasound-Guided Superior Hypogastric Plexus Block: A Cadaveric Feasibility Study with Fluoroscopic Confirmation. Pain practice: the official journal of World Institute of Pain 2017; 17: 192-196
  • 19 Worthington-Kirsch RL, Koller NE. Time course of pain after uterine artery embolization for fibroid disease. Medscape women's health 2002; 7: 4
  • 20 Roth AR, Spies JB, Walsh SM. et al. Pain after uterine artery embolization for leiomyomata: can its severity be predicted and does severity predict outcome?. Journal of vascular and interventional radiology: JVIR 2000; 11: 1047-1052
  • 21 Chou WY, Wang CH, Liu PH. et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006; 105: 334-337